OraPharma, a division of Bausch Health US, LLC
$539.1K 7,610 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Pulse Biosciences, Inc.
Pulse Biosciences, Inc. reported $534,821.47 across General Payments, Research, and Ownership to 72 physicians and teaching hospitals across 72 transactions.
- $534.8K Above-median payer
- All-tracks total
- 72 Below-median volume
- Transactions
- 72 Below-median reach
- Recipients
- #745
- of 1,925 companies
Pulse Biosciences, Inc. reported $534,821.47 across all CMS Open Payments tracks (General + Research + Ownership) to 72 physicians and teaching hospitals in Program Year 2024 - ranking #745 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $534,821.47, averaging $7.4K per recipient.
Pulse Biosciences, Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
22/100
Total payments
F
15/100
Transaction volume
F
10/100
Physician reach
F
11/100
Payment type diversity
D
50/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer pulse-biosciences-inc Pulse Biosciences, Inc.
$534.8K · #745/1,925 · 0.0% industry · PY2024
- TOT $534.8K
- RANK #745
- SHARE 0.0%
- TXN 72
- RCP 72
- CAT 4
- GEN $534.8K
- TOP1 25.6%
- PY 2024
Volume peers
Nearest volume peer: OraPharma, a division of Bausch Health US, LLC ($539.1K)
Pulse Biosciences, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
What the Data Shows for Pulse Biosciences, Inc.
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For Pulse Biosciences, Inc. that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
"Consulting Fee" leads the 4-category general-payment breakdown below at $377.2K (70.5% of General Payments, 38 transactions) - see our methodology for how research and ownership payments are reported separately.
General Payment Breakdown by Type
"Consulting Fee" leads Pulse Biosciences, Inc.'s 4-category general-payment breakdown at $377.2K, 70.5% of the reported total.
Pulse Biosciences, Inc. reports 4 general-payment categories - the top three are Consulting Fee (70.5%), Long-Term Medical Supply or Device Loan (21.5%), and Travel and Lodging (7.6%). The remaining 1 category make up 0.4% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Pulse Biosciences, Inc. divides its payments
How the reported total splits across payment categories
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $377.2K | 38 | 70.5% |
| Long-Term Medical Supply or Device Loan | $115.0K | 16 | 21.5% |
| Travel and Lodging | $40.7K | 4 | 7.6% |
| Food and Beverage | $2.0K | 14 | 0.4% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $449,325.50 (84.0%) of $534,821.47 in this company's General Payments records across 19 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Pulse Biosciences, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Gansevoort Hurlbut Dunningtion
$137,102.67 across 12 reported transactions
- 2
Niv Ad
$130,891.53 across 10 reported transactions
- 3
David Noah Kenigsberg
$80,977.20 across 6 reported transactions
- 4
Ralph P. Tufano
$71,177.05 across 11 reported transactions
- 5
Richard J Harding
$29,177.05 across 5 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Pulse Biosciences, Inc.'s spend rank (#745 of 1,925, top 39% by spend) and concentration rank (#809 of 1,838, top 44% most concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.
View all 12 companies in this HHI neighborhood as a list
- Greiner Bio-One North America, Inc. : $11.6K total payments, HHI 1746
- CashFlow Solutions, LLC : $89.2K total payments, HHI 1745
- Acumed LLC : $3.4M total payments, HHI 1742
- Thermo Fisher Scientific Asheville LLC : $2.2K total payments, HHI 1739
- Albireo Pharma, Inc. : $317.2K total payments, HHI 1739
- Puma Biotechnology, Inc. : $396.8K total payments, HHI 1733
- Pulse Biosciences, Inc. (this company) : $534.8K total payments, HHI 1730
- SS White Burs, Inc. : $65.6K total payments, HHI 1718
- Maquet Cardiovascular L.L.C. : $188.3K total payments, HHI 1714
- GS Solutions, Inc. : $38.7K total payments, HHI 1706
- Mitsubishi Tanabe Pharma Corporation : $92.7K total payments, HHI 1705
- TerSera Therapeutics LLC : $602.9K total payments, HHI 1704
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Pulse Biosciences, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Pulse Biosciences, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Pulse Biosciences, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Dynavax Technologies Corporation
$530.5K 5,747 recipients
Compare payment profiles
OraSure Technologies Inc.
$529.4K 45 recipients
Compare payment profiles
Veryan Medical Incorporated
$525.9K 278 recipients
Compare payment profiles
GC America Inc.
$524.2K 2,479 recipients
Compare payment profiles
Zynex Monitoring Solutions
$546.3K 0 recipients
Compare payment profiles
Put this to use
Pulse Biosciences, Inc. ranks #745 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just Pulse Biosciences, Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.